Scegli la tua regione

Seleziona la regione che meglio si adatta alla tua posizione o alle tue preferenze.

International

Scegli la lingua del sito

Questa impostazione controlla la lingua dell'interfaccia utente, inclusi i pulsanti, i menu e tutto il testo del sito. Seleziona la tua lingua preferita per la migliore esperienza di navigazione.

Scegli le lingue per gli annunci di lavoro

Seleziona le lingue per gli annunci di lavoro che desideri vedere. Questa impostazione determina quali annunci di lavoro ti verranno mostrati.

Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Basilea, Svizzera

Iscriviti per ricevere nuovi annunci di lavoro

Visita il sito web

Informazioni sul datore di lavoro

At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. IOB started operations in 2018.

The institute is constituted as a foundation, granting academic freedom to its scientists.

IOB is guided by the Board of Trustees (general rules and strategy), the Scientific Advisory Board (scientific advice and strategy) and the Executive Board (leadership and operations). The Executive Board consists of three co-directors who share the responsibility of guiding the new organization.

Why IOB?

Globally, the prevalence of eye diseases is constantly rising. For most of them, there is no effective therapy available.

In aging societies, disorders such as macular degeneration or glaucoma constitute a leading cause of disability and loss of independent lifestyle.

Worldwide and especially in Asia, myopia – or short-sightedness – is on a steep incline with up to 90% of teenagers being affected in some regions.

At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to tackle these challenges, by advancing the understanding of eye diseases and to develop new therapies for vision loss.